Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
pyrimethamine (daraprim) (3 trials)
sulfadoxine (3 trials)
Malaria (Phase 4)
Trials (3 total)
Trial APIs (2 total)